BlueCrest Capital Management Ltd - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664WAB1. A total of 22 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
BlueCrest Capital Management Ltd ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q4 2022$1,844,962
-32.3%
3,350,000
-30.9%
0.05%
-39.5%
Q3 2022$2,726,000
-8.6%
4,850,000
-9.3%
0.08%
-29.6%
Q2 2022$2,981,000
-4.0%
5,350,000
-10.8%
0.12%
+13.9%
Q1 2022$3,105,000
-16.2%
6,000,000
-14.3%
0.10%
-15.8%
Q4 2021$3,705,0007,000,0000.12%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q1 2023
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 29,679,000$23,720,0007.42%
SILVERBACK ASSET MANAGEMENT LLC 11,750,000$6,487,1750.92%
DCF Advisers, LLC 1,550,000$884,0000.57%
Context Capital Management, LLC 14,764$8,274,0000.56%
AGF Investments LLC 7,000,000$3,872,0000.36%
WHITEBOX ADVISORS LLC 19,600,000$10,682,0000.30%
Pentwater Capital Management LP 46,411,000$26,134,0000.29%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$11,591,0000.27%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 24,000,000$13,275,0000.24%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 14,900,000$8,493,0000.12%
View complete list of ESPERION THERAPEUTICS INC NE shareholders